Skip to main content
Login
Contact
Subscribe
Search form
Search
The Borger News-Herald
Home
Forms
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Calendar
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Biospecifics Tech Cp
(NQ:
BSTC
)
88.53
USD
UNCHANGED
Last Price
Updated: 4:21 PM EST, Dec 1, 2020
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Biospecifics Tech Cp
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Relative Strength Alert For Biospecifics Technologies
August 14, 2017
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Tags
Stocks
From
Market News Video
BRIEF-BioSpecifics Technologies reports Q2 earnings per share $0.36
August 09, 2017
* BioSpecifics Technologies Corp reports second quarter 2017 financial results
Tags
companyNews
From
Reuters: Company News
BioSpecifics Technologies Corp. Reports Second Quarter 2017 Financial Results
August 09, 2017
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product marketed...
From
PR Newswire
PXSG's Underlying Holdings Could Mean 13% Gain Potential
June 07, 2017
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
BioSpecifics Technologies Corp. to Present at the Jefferies 2017 Healthcare Conference
June 02, 2017
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product marketed...
From
PR Newswire
Can This Biotech Stock With 645% EPS Growth Launch New Breakout?
June 02, 2017
Innoviva shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
Tags
IBD Data Stories
From
Investor's Business Daily
Pharma Stock With Triple-Digit Growth Forming Blotchy Base
May 24, 2017
A Relative Strength Rating upgrade for Ionis Pharmaceuticals shows improving technical performance. Will it continue?
Tags
IBD Data Stories
From
Investor's Business Daily
Biotech Breakout Ahead? Incyte Rising On Success With Merk, Bristol-Myers
May 19, 2017
A Relative Strength Rating upgrade for Incyte shows improving technical performance.
Tags
IBD Data Stories
From
Investor's Business Daily
Recovering Biotech Stock Enters Buy Zone; Earns Rating Upgrade
May 18, 2017
Regeneron Pharmaceutical saw an improvement in its IBD SmartSelect Composite Rating Thursday, from 94 to 96.
Tags
IBD Data Stories
From
Investor's Business Daily
How Ionis Helped Rival Alnylam — But Tanked Itself — On A Key Trial
May 15, 2017
Alnylam stock rocketed to a 19-month high Monday after a Phase 3 trial from rival Ionis de-risked a key Alnylam drug while indicating serious safety questions for Ionis' drug.
Tags
Technology
From
Investor's Business Daily
BRIEF-Biospecifics Technologies reports Q1 earnings per share $0.46
May 10, 2017
* Biospecifics Technologies Corp. reports first quarter 2017 financial results
Tags
companyNews
From
Reuters: Company News
BioSpecifics Technologies Corp. Reports First Quarter 2017 Financial Results
May 10, 2017
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product marketed...
From
PR Newswire
Small Cap Best And Worst - Thursday, May 4
May 04, 2017
The average small cap score is 50.03. The score has averaged 50.47 over the past four weeks.
Tags
Healthcare
Financial
Consumer Goods
From
Blogs - TalkMarkets
BioSpecifics Technologies Corp. Initiates Phase 1 Clinical Trial of XIAFLEX for Treatment of Uterine Fibroids
April 18, 2017
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product marketed...
From
PR Newswire
Small Cap Best And Worst Stocks - Thursday, April 6
April 06, 2017
The average small cap score is 52.76 and the average score over the past four weeks is 53.08.
Tags
Stocks / Equities
From
Blogs - TalkMarkets
BioSpecifics Technologies Corp. to Present at the 16th Annual Needham Healthcare Conference
March 29, 2017
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product...
From
PR Newswire
BRIEF-Biospecifics Technologies Q4 earnings per share $0.40
March 15, 2017
* Biospecifics Technologies Corp reports fourth quarter and full year 2016 financial results
Tags
companyNews
From
Reuters: Company News
BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2016 Financial Results
March 15, 2017
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product...
From
PR Newswire
Top Biotech May 'Unveil' Breakthrough Treatment — And Breakout Move
March 07, 2017
Leading biotech stock Celgene (CELG) is within striking distance of a breakout after reporting encouraging results in Unveil, "the first prospective, randomized, controlled study to — evaluate the...
Tags
IBD Stock Analysis
From
Investor's Business Daily
BioSpecifics Technologies Corp. to Present at NobleCon13 - Noble Capital Markets' Thirteenth Annual Investor Conference
January 24, 2017
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product...
From
PR Newswire
The Life Sciences Report Announces 19 Companies Selected for the 2017 Small-Cap Biotech Watchlist
January 05, 2017
From
Marketwired News Releases
BioSpecifics Technologies Corp. Announces Positive Data from Phase 2b Study of CCH in Patients with Cellulite
November 17, 2016
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product...
From
PR Newswire
BRIEF-Biospecifics Technologies reports Q3 earnings per share $0.42
November 09, 2016
* Biospecifics Technologies Corp - total revenue for Q3 ended September 30, 2016 was $6.9 million, compared to $6.3 million
Tags
companyNews
From
Reuters: Company News
BioSpecifics Technologies Corp. Reports Third Quarter 2016 Financial Results
November 09, 2016
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product...
From
PR Newswire
BioSpecifics Technologies Corp. to Present at Stifel 2016 Healthcare Conference
November 08, 2016
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product...
From
PR Newswire
BioSpecifics Technologies Corp. to Report Third Quarter 2016 Financial Results on Wednesday, November 9, 2016
November 02, 2016
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product...
From
PR Newswire
18 Stocks Which Rallied Four Days, Then Sold Off Yesterday
September 30, 2016
The following stocks posted four-day rallies spanning the trading days from September 23 to September 28 and then saw profit ...
Tags
Trading Ideas
HQCL
Markets
From
Benzinga
Mid-Morning Market Update: Markets Open Higher; Lennar Tops Q3 Expectations
September 20, 2016
Following the market opening Tuesday, the Dow traded up 0.44 percent to 18,200.26 while the NASDAQ climbed 0.39 percent ...
Tags
BSTC
TBRA
Global
From
Benzinga
25 Stocks Which Rallied Three Days
September 16, 2016
The list of below stocks is notable as the shares have rallied for three days in a row spanning the trading days from September 13 ...
Tags
GNC
CEMP
EDU
From
Benzinga
BioSpecifics Technologies Corp. to Present at Two Upcoming September Conferences
September 02, 2016
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product...
From
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.